Graham C. Parry

6.0k total citations
75 papers, 5.0k citations indexed

About

Graham C. Parry is a scholar working on Hematology, Immunology and Cancer Research. According to data from OpenAlex, Graham C. Parry has authored 75 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 28 papers in Immunology and 28 papers in Cancer Research. Recurrent topics in Graham C. Parry's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Protease and Inhibitor Mechanisms (20 papers) and Cell Adhesion Molecules Research (16 papers). Graham C. Parry is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Protease and Inhibitor Mechanisms (20 papers) and Cell Adhesion Molecules Research (16 papers). Graham C. Parry collaborates with scholars based in United States, United Kingdom and Austria. Graham C. Parry's co-authors include Nigel Mackman, Ronald R. Cobb, Andrew P. Mazar, Katherine A. Felts, Paul Oeth, Jonathan Erlich, David E. Shaw, Teresa Martin, Véronique Ollivier and Dominique de Prost and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Graham C. Parry

75 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graham C. Parry United States 36 1.7k 1.4k 1.4k 1.2k 814 75 5.0k
David H. Lovett United States 50 2.5k 1.4× 1.0k 0.7× 1.8k 1.3× 693 0.6× 995 1.2× 126 6.6k
David L. Boyle United States 48 3.2k 1.9× 2.3k 1.6× 1.4k 1.0× 853 0.7× 1.5k 1.8× 110 7.1k
Adam S. Asch United States 31 1.7k 1.0× 1.0k 0.7× 579 0.4× 991 0.8× 1.3k 1.6× 98 4.6k
Manuel O. Landázuri Spain 47 2.7k 1.6× 2.8k 1.9× 1.8k 1.3× 507 0.4× 900 1.1× 109 6.9k
Inés Martín-Padura Italy 34 3.1k 1.8× 1.1k 0.8× 672 0.5× 456 0.4× 906 1.1× 50 5.9k
Yoshiro Maru Japan 35 3.3k 1.9× 1.2k 0.9× 900 0.6× 652 0.5× 1.5k 1.9× 89 5.4k
J. David Becherer United States 35 2.0k 1.2× 1.1k 0.8× 847 0.6× 481 0.4× 1.4k 1.8× 51 4.4k
Masanobu Kobayashi Japan 36 1.8k 1.1× 996 0.7× 863 0.6× 536 0.5× 1.0k 1.2× 131 4.1k
Kris A. Reedquist Netherlands 43 2.9k 1.7× 2.1k 1.4× 508 0.4× 585 0.5× 1.1k 1.3× 91 5.6k
Lindsey A. Miles United States 41 2.4k 1.4× 670 0.5× 3.2k 2.3× 1.9k 1.6× 724 0.9× 99 6.2k

Countries citing papers authored by Graham C. Parry

Since Specialization
Citations

This map shows the geographic impact of Graham C. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham C. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham C. Parry more than expected).

Fields of papers citing papers by Graham C. Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham C. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham C. Parry. The network helps show where Graham C. Parry may publish in the future.

Co-authorship network of co-authors of Graham C. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Graham C. Parry. A scholar is included among the top collaborators of Graham C. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham C. Parry. Graham C. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rajagopal, Vaishnavi, Nina C. Leksa, Ronald D. Gorham, et al.. (2023). SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb. Blood Advances. 7(16). 4258–4268. 5 indexed citations
2.
Huck, Ian, Lilley Leong, Tony Byun, et al.. (2023). PB1311 Prophylactic Efficacy of VGA039, An Anti-Protein S Monoclonal Antibody, In A Novel Non-Human Primate Model of Acquired Von Willebrand Disease. Research and Practice in Thrombosis and Haemostasis. 7. 101253–101253. 3 indexed citations
3.
Hussain, Sami, Kate Markham, Tony Byun, et al.. (2023). Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s. Clinical Immunology. 251. 109629–109629. 8 indexed citations
4.
Derhaschnig, Ulla, Christian Schoergenhofer, Christa Firbas, et al.. (2019). Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid. Journal of Investigative Dermatology. 139(12). 2417–2424.e2. 26 indexed citations
5.
Jilma, Bernd, James C. Gilbert, Sandip Panicker, et al.. (2016). Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD). Blood. 128(22). 2435–2435. 3 indexed citations
6.
Zhang, Ling, Graham C. Parry, & Eugene G. Levin. (2013). Inhibition of Tumor Cell Migration by LD22-4, an N-Terminal Fragment of 24-kDa FGF2, Is Mediated by Neuropilin 1. Cancer Research. 73(11). 3316–3325. 15 indexed citations
7.
Buren, George Van, Michael J. Gray, Nikolaos A. Dallas, et al.. (2007). A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) combined with bevacizumab inhibits the growth of colon cancer metastases in the liver: Differential effects mediated by tumor burden.. Molecular Cancer Therapeutics. 6. 2 indexed citations
8.
Li, Yongdong, Graham C. Parry, Liqing Chen, et al.. (2006). An Anti-urokinase Plasminogen Activator Receptor (uPAR) Antibody: Crystal Structure and Binding Epitope. Journal of Molecular Biology. 365(4). 1117–1129. 18 indexed citations
10.
Callahan, Jennifer, et al.. (2005). In vitro and in vivo characterization of a monoclonal antibody, ATN-658, targeting the uPA system. Cancer Research. 65. 1454–1455. 2 indexed citations
11.
Bauer, Todd W., Fan Fan, Wenbiao Liu, et al.. (2005). Insulinlike Growth Factor-I???Mediated Migration and Invasion of Human Colon Carcinoma Cells Requires Activation of c-Met and Urokinase Plasminogen Activator Receptor. Annals of Surgery. 241(5). 748–758. 54 indexed citations
12.
Tarui, Takehiko, Nicholas M. Andronicos, Andrew P. Mazar, et al.. (2003). Critical Role of Integrin α5β1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling. Journal of Biological Chemistry. 278(32). 29863–29872. 62 indexed citations
13.
Idell, Steven, Andrew P. Mazar, Douglas B. Cines, et al.. (2002). Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits. American Journal of Respiratory and Critical Care Medicine. 166(7). 920–926. 36 indexed citations
14.
Doñate, Fernando, et al.. (2002). Inhibition of Cell Migration and Angiogenesis by the Amino-terminal Fragment of 24kD Basic Fibroblast Growth Factor. Journal of Biological Chemistry. 277(34). 31056–31061. 19 indexed citations
15.
Martin, Teresa, Pina M. Cardarelli, Graham C. Parry, Katherine A. Felts, & Ronald R. Cobb. (1997). Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1. European Journal of Immunology. 27(5). 1091–1097. 281 indexed citations
16.
Lin, Kurt Ming-Chao, et al.. (1997). Shear stress induction of the tissue factor gene.. Journal of Clinical Investigation. 99(4). 737–744. 188 indexed citations
17.
Ollivier, Véronique, Graham C. Parry, Ronald R. Cobb, Dominique de Prost, & Nigel Mackman. (1996). Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells. Journal of Biological Chemistry. 271(34). 20828–20835. 309 indexed citations
18.
Cobb, Ronald R., et al.. (1996). A benzothiophene‐carboxamide is a potent inhibitor of IL‐1β induced VCAM‐1 gene expression in human endothelial cells. FEBS Letters. 382(3). 323–326. 22 indexed citations
19.
Cobb, Ronald R., Katherine A. Felts, Graham C. Parry, & Nigel Mackman. (1996). D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.. Molecular Pharmacology. 49(6). 998–1004. 31 indexed citations
20.
Byrne, Micheline, et al.. (1990). A prospective study of human papillomavirus infection of the cervix. Cytopathology. 1(6). 329–337. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026